WHAT IS SPRAVATO?
Spravato (esketamine) nasal spray is an FDA-approved treatment specifically developed for adults with treatment-resistant depression. Unlike standard antidepressants that may take weeks to show effects, Spravato offers rapid relief by acting on NMDA receptors in the brain, leading to significant improvements in depressive symptoms within a much shorter time frame.
Administered under the careful supervision of medical professionals, Spravato provides a fast and effective option for individuals in need of quick relief from severe depression. Its rapid-acting nature is especially beneficial for those facing critical depressive episodes.
HOW DOES SPRAVATO WORK
The active ingredient in Spravato, esketamine, targets NMDA receptors in the brain, which are critical to mood regulation and cognitive function. By modulating these receptors, Spravato increases levels of glutamate, a neurotransmitter essential for brain communication and synaptic plasticity. This process, known as synaptogenesis, helps alleviate depressive symptoms and improve overall mood.